Related Experiment Video
Updated: Jun 3, 2026
12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
Optimal serial dilutions designs for drug discovery experiments.
Alexander N Donev1, Randall D Tobias
1School of Mathematics, University of Manchester, Manchester, United Kingdom. a.n.donev@manchester.ac.uk
Journal of Biopharmaceutical Statistics
|March 29, 2011
Summary
This study introduces a new method for optimizing dose-response study designs in drug discovery. It enhances experimental efficiency and reduces costs without sacrificing data quality.
Area of Science:
- Pharmacology and Drug Discovery
- Biostatistics
- Experimental Design
Background:
- Dose-response studies are crucial in drug discovery, often involving serial dilution experiments with numerous compounds.
- Current experimental designs may not be optimally tailored to specific stages of the drug discovery process.
Purpose of the Study:
- To propose a novel methodology for selecting key parameters in dose-response study designs.
- To optimize experimental efficiency and cost-effectiveness in drug discovery while maintaining data integrity.
Main Methods:
- The study employs and extends optimal design theory, specifically population D- and D(S)-optimality.
- Key design parameters include maximum dose, dilution factor, number of concentrations, and replication per concentration.
Main Results:
- A method is presented for selecting optimal dose-response study parameters based on the drug discovery stage.
- The defined optimality criteria (D- and D(S)-optimality) effectively evaluate the precision of compound potency estimation.
Conclusions:
- The proposed methodology offers a practical approach to designing more efficient and cost-effective dose-response studies.
- Implementing these optimized designs can lead to significant cost reductions in drug discovery experiments without compromising data quality.
Related Concept Videos
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
01:28Methods of Medium Optimization
Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...